Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study

This study aimed to investigate the cost-effectiveness of preimplantation genetic diagnosis (PGD) for the reproductive choices of patients with heritable retinoblastoma. The study modelled the costs of three cycles of in-vitro fertilization (IVF) and PGD across all uptake rates of PGD, number of chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schofield, D., Zeppel, M.J.B., Staffieri, S., Shrestha, R.N., Jelovic, D., Lee, E., Jamieson, R.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301166/
https://www.ncbi.nlm.nih.gov/pubmed/32577540
http://dx.doi.org/10.1016/j.rbms.2020.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301166/
https://www.ncbi.nlm.nih.gov/pubmed/32577540
http://dx.doi.org/10.1016/j.rbms.2020.03.001

Ejemplares similares